Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;72(1):66-71.
doi: 10.1007/s13224-021-01502-0. Epub 2021 Jun 11.

Survival After Pelvic Exenteration for Cervical Cancer

Imen Bouraoui  1 , Hanen Bouaziz  1 , Nesrine Tounsi  1 , Racha Ben Romdhane  1 , Monia Hechiche  1 , Maher Slimane  1 , Khaled Rahal  1
Affiliations

Survival After Pelvic Exenteration for Cervical Cancer

Imen Bouraoui et al. J Obstet Gynaecol India. 2022 Feb.

Abstract

Background: The purpose of this work was to identify the results of pelvic exenteration for recurrent, persistent or locally advanced cervical cancer in terms of survival performed for 41 patients in Salah Azaiez Institute.

Patients and methods: We conducted a retrospective unicentric study. The association between PE and OS was estimated using the method of Kaplan-Meier using SPSS ver 24.

Results: Median age at the time of intervention was 53.9 years old. FIGO stage IIB was the most frequent (46.3%). Eighteen patients had pelvic exenteration after neoadjuvant treatment. Resection margins were free of tumor in 83.3% of cases. Twenty-three patients underwent pelvic exenteration for recurrence of cervical cancer treated. The median time of recurrence was 23.4 months. Free resection margins were obtained in 69.5% of cases. Postoperative complications were noted in 61% of patients. Two deaths were seen in the early postoperative period. After a median follow-up of 40.5 months, 24.4% of recurrences were noted. Overall survival at 5 years was 51% and recurrence-free survival at one year was 39%. Prognostic factors which impact overall and recurrence-free survival were the size of recurrence and resection margins after exenteration. The time between the end of initial treatment and recurrence was the only predictive factor of recurrence after pelvic exenteration.

Conclusion: Pelvic exenteration remains a curative treatment of cervical cancer in certain indications despite high morbidity. A rigorous preoperative selection of candidate may reduce the morbidity and improve the survival of patients.

Keywords: Cervical cancer; Locally advanced; Pelvic exenteration; Recurrence; Survival.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThe authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Specimen of anterior pelvic exenteration with total colpectomy
Fig. 2
Fig. 2
Overall survival of patients who had pelvic exenteration
Fig. 3
Fig. 3
Disease free survival of patients who had pelvic exenteration
See this image and copyright information in PMC

References

    1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Rozario SD, da Silva IF, Koifman RJ, et al. Characterization of women with cervical cancer assisted at Inca by histological type. Rev Saúde Pública. 2019;53:88. doi: 10.11606/S1518-8787.2019053001218. - DOI - PMC - PubMed
    1. Sardain H, Lavoué V, Foucher F, et al. L’exentération pelvienne curative en cas de récurrence d’un cancer du col de l’utérus à l’ère de la radio-chimiothérapie concomitante: revue de la littérature. J Gynécol Obstét Biol Reprod. 2016;45(4):315–329. doi: 10.1016/j.jgyn.2016.01.004. - DOI - PubMed
    1. Marnitz S, Köhler C, Müller M, et al. Indications for primary and secondary exenterations in patients with cervical cancer. Gynecol Oncol. 2006;103(3):1023–1030. doi: 10.1016/j.ygyno.2006.06.027. - DOI - PubMed
    1. Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma. A one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer. 1948;1(2):177–83. doi: 10.1002/1097-0142(194807)1:2<177::AID-CNCR2820010203>3.0.CO;2-A. - DOI - PubMed

LinkOut - more resources